logo.jpg
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
June 01, 2020 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif. and JUPITER, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme...
logo.jpg
Codexis to Participate in Two Virtual Investment Conferences
May 27, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment...
logo.jpg
Codexis to Present at the UBS Virtual Healthcare Conference
May 11, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare...
logo.jpg
Codexis Reports First Quarter 2020 Financial Results
May 07, 2020 16:05 ET | Codexis, Inc.
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference...
logo.jpg
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 06, 2020 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone...
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
May 05, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as...
logo.jpg
Codexis to Hold First Quarter 2020 Conference Call on May 7
April 30, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after...
logo.jpg
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
February 27, 2020 16:05 ET | Codexis, Inc.
2019 total revenues increased 13% to $68.5 million with product revenue up 15% and R&D revenue up 11%  Ten customers contributed more than $1 million each to 2019 revenues Introduces...
logo.jpg
Codexis to Present at Two Investment Conferences in March
February 25, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
logo.jpg
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
February 20, 2020 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2019 fourth quarter and full year financial...